Cargando…

Phenotypic Variability of c.436delC DCAF17 Gene Mutation in Woodhouse-Sakati Syndrome

Case series Patients: 38, female • 28, female • 41, female • 18, female • 23, male Final Diagnosis: Woodhouse-Sakati syndrome Symptoms: Hypogonadism • dystonia • alopecia • hearing loss • diabetes Medication: — Clinical Procedure: — Specialty: Endocrinology and Metabolic OBJECTIVE: Rare disease BACK...

Descripción completa

Detalles Bibliográficos
Autores principales: Almeqdadi, Mohammad, Kemppainen, Jennifer L., Pichurin, Pavel N., Gavrilova, Ralitza H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5881453/
https://www.ncbi.nlm.nih.gov/pubmed/29574468
http://dx.doi.org/10.12659/AJCR.907395
Descripción
Sumario:Case series Patients: 38, female • 28, female • 41, female • 18, female • 23, male Final Diagnosis: Woodhouse-Sakati syndrome Symptoms: Hypogonadism • dystonia • alopecia • hearing loss • diabetes Medication: — Clinical Procedure: — Specialty: Endocrinology and Metabolic OBJECTIVE: Rare disease BACKGROUND: Woodhouse-Sakati syndrome (WSS) is a rare autosomal recessive genetic condition that was first described in 1983. Since its original description, approximately 50 cases have been reported with various clinical signs and symptoms. Characteristics include progressive neurologic deterioration with extrapyramidal involvement and polyendocrinopathy most notable for hypogonadism starting in early adolescence. Clinical presentation is variable, and a subset of patients may have additional features, such as premature aging, alopecia, distinctive facial features, cognitive impairment, or deafness. CASE REPORT: We illustrate the phenotypic variability of 5 patients with WSS due to the previously reported homozygous single nucleotide deletion c.436delC in the DCAF17 gene, identified in 2008. Despite identical genetic alteration, our 5 patients had various clinical features among them and compared with previously reported cases with the same pathogenic mutation. CONCLUSIONS: The phenotypic variability of WSS due to c.436delC founder mutation may have a wider range than previously recognized.